Quinolones in the treatment of typhoid fever

Drugs

Volumn 58, Issue SUPPL. 2, 1999, Pages 52-54

  Erdal Akalin, H ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PEDIATRICS; TYPHOID FEVER;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; TYPHOID FEVER;

EID: 0345465927     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00010     Document Type: Conference Paper

References (31)

1. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986; 8: 329-49
2. Mermin JH, Townes JM, Gerber M, et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998; 158: 633-8
3. Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 1997; 24 Suppl. 1: S106-9
4. Bryan JP, Rocha H, Scheld WM. Problems in salmonellosis: rationale for clinical trials with newer betalactams and quinolones. Rev Infect Dis 1986; 8: 189-209
5. Centers for Disease Control. Typhoid fever - Mexico. MMWR Morb Mortal Wkly Rep 1972; 21: 177-8
6. Anand AC, Kataria VK, Singh W, et al. Epidemic multiresistant enteric fever in eastern India. Lancet 1990; 335: 352
7. Threlfall EJ, Ward LR, Rowe B, et al. Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis 1992; 11: 989-93
8. Albert MJ, Haider K, Nahar S, et al. Multiresistant Salmonella typhi in Bangladesh. J Antimicrob Chemother 1991; 27: 554-5
9. Tinya-Superable JF, Castillo MTG, Magboo FP, et al. Multidrug resistant Salmonella typhi outbreak in metro Manila, Philippines, Southeast Asia. J Trop Med Public Health 1995; 26 Suppl. 2: 37-8
10. Dupont HL. Quinolones in Salmonella typhi infection. Drugs 1993; 45 Suppl. 3: 119-24
11. Girgis N, Sultan Y, Hammad O, et al. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone, and aztreonam in the treatment of multidrug-resistant Salmonella septicemia in children. Pediatr Infect Dis 1995; 14: 603-5
12. Gür D, Kocagöz S, Ünal S, et al. Comparative in vitro activity of trovafloxacin against Gram-negative and Gram-positive pathogens. Clin Microbiol Infect 1998; 4: 530-2
13. Saha MR, Dutta P, Bhattacharya SK, et al. Occurrence of multi-drug resistant Salmonella typhi in Calcutta. Indian J Med Res 1992; 95: 179-80
14. Dutta P, Rasaily R, Saha MR, et al. Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrob Agents Chemother 1993; 37: 1197-9
15. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. N Engl J Med 1991; 324: 384-94
16. Limson BM. Short course quinolone therapy of typhoid fever in developing countries. Drugs 1995; 49 Suppl. 2: 136-8
17. Sen S, Goyal RS, Dev R. Ciprofloxacin in the management of multidrug resistant typhoid fever. Indian Pediatr 1991; 28: 417-9
18. Vinh H, Wain J, Hanh VTN, et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 1996; 40: 958-61
19. Uwaydah AK, al Soub H, Matar I. Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. J Antimicrob Chemother 1992; 30: 707-11
20. Agalar C, Usubutun S, Tutuncu E, et al. Comparison of two regimens for ciprofloxacin treatment of enteric infections. Eur J Clin Microbiol Infect Dis 1997; 16: 803-6
21. Alam MN, Haq SA, Das KK, et al. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. Am J Trop Med Hyg 1995; 53: 306-11
22. Arnold K, Hong CS, Nelwan R, et al. Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever. Am J Med 1993; 94 (3A): 195S-200S
23. Chukwuani CM, Onyemelukwe GC, Okonkwo PO, et al. Fleroxacin vs ciprofloxacin in the management of typhoid fever. Clin Drug Invest 1998; 16: 279-88
24. Bryskier A, Zribi A, Ould Rouis B, et al. Typhoid fever: five day therapy with ofloxacin, preliminary results. Proceedings of the 4th International Symposium on New Quinolones; 1992 Aug 27-29; Munich: 223
25. Ünal S, Hayran M, Tuncer S, et al. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial. Antimicrob Agents Chemother 1996; 40: 2898-900
26. Wallace MR, Yousif AA, Mahroos GA, et al. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. Eur J Clin Microbiol Infect Dis 1993; 12: 907-10
27. Nguyen TC, Solomon T, Mai XT, et al. Short course of ofloxacin for the treatment of enteric fever. Trans R Soc Trop Med Hyg 1997; 91: 347-9
28. Hien TT, Bethell DB, Hoa NT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20: 917-23
29. Secmeer G, Kanra G, Figen G, et al. Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children. Acta Paediatr Jpn 1997; 39: 218-21
30. Thomsen LL, Paerregaard A. Treatment with ciprofloxacin in children with typhoid fever. Scand J Infect Dis 1998; 30: 355-7
31. Rowe B, Threlfall EJ, Ward LR. Ciprofloxacin-resistant Salmonella typhi in the UK. Lancet 1995; 346: 1302